Pointers PE invests ₩15B in ReMed…"growth opportunity in global neurotech"
Predicted impact: Medium
₩15B investment and share cancellation of ₩1.9B; convertible bond amendment noted.
Remed리메드
302550 · KOSDAQ · ₩302550 · 리메드
₩2,290▲ ₩75 (3.39%)End-of-day · Oct 30, 2026 · End-of-day prices.
Pointers PE invests ₩15B in REMED, expanding into pain management and obesity treatment market
Predicted impact: Medium
Convertible bond worth about 20% of market value, but LF Investment's ₩15B deal was already reported.
Rimed to Cancel Shares Worth ₩1.9B… "Enhancing Shareholder Value"
Predicted impact: Medium
Share cancellation of about ₩1.9B is roughly 2.6% of market value, but tied to the same CB decision.
LF Investment to Invest ₩15B in REMED; Becomes No. 2 Shareholder upon CB Conversion
Predicted impact: Medium· Actual: +7.0% vs sector, volume 0.6× normal (5 trading days)
₩15B investment via CB conversion making LF No. 2 holder; size versus ~₩73B market value is about 20%.
Also known as: Remed / 리메드 / 302550 / KRX:302550
Source: KRX statistical information